Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
No tobacco leaf
Tissue and bone loss around the roots of the teeth
While CMS considered a longer period until a revision is completed, such as the 36-month period provided by the Medicaid Drug Rebate Program (MDRP) for AMP restatements in 447.510(d)(3), CMS believes that a 12-month reconciliation period is appropriate for the Part B rebate program because of requirements to submit timely and accurate ASP data (specified in 414.806(b)), and it provides sufficient time to capture the majority of updates to the data specified in proposed 427.301 while closing out (except for the proposed circumstances in proposed 427.501(d)(2) regarding CMS' identification of mathematical errors or manufacturer misreporting) the calculation of the rebate amount for a Part B rebatable drug for an applicable calendar quarter within a reasonable time period after the Rebate Report is issued
We are proposing a work RVU of 0.21 for HCPCS code G0138 based on a crosswalk from CPT code 96365 ( Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug)
US$ 21.60
US$ 27.48
US$ 22.74
US$ 23.88
US$ 25.30
US$ 20.03
US$ 27.56
US$ 29.75
